✦ LIBER ✦

Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A southwest oncology group study

✍ Scribed by Antoinette J. Wozniak; Brent A. Blumenstein; E. David Crawford; Michael Boileau; Saul E. Rivkin; William S. Fletcher

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 381 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930615)71:12<3975::aid-cncr2820711229>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adriamycin and cyclophosphamide versus h

Adriamycin and cyclophosphamide versus hydroxyurea in advanced prostatic cancer. A randomized Southwest Oncology Group study

✍ Ronald L. Stephens; Clarence Vaughn; Montague Lane; John Costanzi; Robert O'brya 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB 👁 1 views

Phase III trial of cyclophosphamide vers

Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer: A hoosier oncology group study

✍ Scott Saxman; Rafat Ansari; Ray Drasga; Michael Miller; Ben Wheeler; John McClea 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB

Phase II study of 5-fluorouracil and fol

Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer: A Southwest Oncology Group study

✍ Giuseppe Colucci 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

n the article published in Cancer entitled "Phase I1 study of 5-fluoro-I uracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study,"' the authors erroneously quoted the results of our study and we request a correction. In the results of our

Phase II study of 5-fluorouracil and fol

Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study

✍ Jeffrey L. Berenberg; Catherine Tangen; John S. Macdonald; Laura F. Hutchins; Ro 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Adriamycin in combination for the treatm

Adriamycin in combination for the treatment of breast cancer. A southwest oncology group study

✍ Dr. B. Tranum; B. Hoogstraten; A. Kennedy; C. B. Vaughn; B. Samal; T. Thigpen; S 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 1 views

Patients with advanced breast cancer who had not previously received chemotherapy were treated on a three-arm prospective study: adriamycin day 1 plus 5-FU on day 1 and 8 (AF), adriamycin day 1 , plus 5-FU day 1 and 8 , and cyclophosphamide day 1 (AFC), and adriamycin day 1 plus 5-FU day 1 and 8 , c

The eastern cooperative oncology group e

The eastern cooperative oncology group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer

✍ Geoffrey Falkson; Rebecca S. Gelman; Douglass C. Tormey; Frank J. Cummings; Paul 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 1 views

Data on 162 women (90 premenopausal and 72 postmenopausal) with metastatic breast cancer randomized to receive cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF) on two Eastern Cooperative Oncology Group (ECOG) protocols were analyzed. Twenty-three percent had complete remission; 39